BioCryst Pharmaceuticals Inc

BCRXNASDAQUSD
8.84 USD
0.18 (1.96%)🟢LIVE (AS OF 11:09 AM EDT)
🟢Market: OPEN
Open?$9.03
High?$9.08
Low?$8.75
Prev. Close?$9.02
Volume?609.2K
Avg. Volume?4.6M
VWAP?$8.88
Rel. Volume?0.13x
Bid / Ask
Bid?$8.80 × 600
Ask?$8.81 × 1.3K
Spread?$0.01
Midpoint?$8.81
Valuation & Ratios
Market Cap?2.3B
Shares Out?254.2M
Float?199.3M
Float %?94.6%
P/E Ratio?N/A
P/B Ratio?-4.14
EPS?-$1.80
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Employees
435
Market Cap
2.3B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
1994-03-03
Address
4505 EMPEROR BOULEVARD
DURHAM, NC 27703
Phone: 919-859-1302
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.91Adequate
Quick Ratio?1.88Adequate
Cash Ratio?0.88Adequate
Debt/Equity?-1.53Low
ValuationATTRACTIVELY VALUED
Score
93/100
P/E?
N/A
P/B?
-4.14CHEAP
P/S?
2.59CHEAP
P/FCF?
7.4CHEAP
EV/EBITDA?
-7.8CHEAP
EV/Sales?
3.35FAIR
Returns & Efficiency
ROE?
82.7%STRONG
ROA?
-98.5%WEAK
Cash Flow & Enterprise
FCF?$310.4M
Enterprise Value?$3.0B
Fundamentals ratios updated end of day